Knoll Capital Management, LLC Entera Bio Ltd. Transaction History
Knoll Capital Management, LLC
- $155 Million
- Q4 2024
A detailed history of Knoll Capital Management, LLC transactions in Entera Bio Ltd. stock. As of the latest transaction made, Knoll Capital Management, LLC holds 5,881,879 shares of ENTX stock, worth $11.5 Million. This represents 7.89% of its overall portfolio holdings.
Number of Shares
5,881,879
Previous 3,881,879
51.52%
Holding current value
$11.5 Million
Previous $7.38 Million
65.88%
% of portfolio
7.89%
Previous 3.64%
Shares
6 transactions
Others Institutions Holding ENTX
# of Institutions
18Shares Held
7.52MCall Options Held
24.5KPut Options Held
0-
Schonfeld Strategic Advisors LLC New York, NY632KShares$1.23 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT414KShares$806,7770.13% of portfolio
-
Northern Trust Corp Chicago, IL212KShares$414,3410.0% of portfolio
-
Perigon Wealth Management, LLC San Francisco, CA146KShares$284,3930.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny61.8KShares$120,5100.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $56.2M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...